Metabolism and degradation products of recombinant human insulin-like growth factor-I in lysosomes of rat kidney

Xenobiotica

Volumn 29, Issue 3, 1999, Pages 281-295

  Tanaka, Y ^a   Tamoto, H ^a   Tozuka, Z ^a   Sato, A ^a   Kimura, T ^b  

^a ASTELLAS PHARMA INC   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLSULFONYL FLUORIDE; CATHEPSIN; CYSTEINE PROTEINASE INHIBITOR; GLUTATHIONE; LEUCINE CHLOROMETHYL KETONE; LEUPEPTIN; RECOMBINANT SOMATOMEDIN C; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG DEGRADATION; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY CELL; LYSOSOME; MALE; MASS SPECTROMETRY; MOLECULAR WEIGHT; NONHUMAN; PROTEIN DEGRADATION; PROTEIN STRUCTURE; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEQUENCE ANALYSIS;

ANIMALIA;

EID: 0033025006     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982599238678     Document Type: Article

References (42)

1. AULETTA, M., NIELSEN, F. C. and GAMELTOFT, S., 1992, Receptor-mediated endocytosis and degradation of insulin-like growth factor I and II in neonatal rat astrocytes. Journal of Neuroscience Research, 31, 14-20.
2. BAKER, E. N., BLUNDELL, T. L., CUTFIELD, J. F., CUTFIELD, S. M., DODSON, E. J., DODSON, G. G., HODGKIN, D. M., HUBBARD, R. E., ISAACS, N. W., REYNOLDS, C. D., SAKABE, N. and VIJAYAN, N. M. 1988, The structure of 2Zn pig insulin crystals at 1.5 A resolution. Philosophical Transactions of the Royal Society in London. Series B: Biological Science, 319, 369-456.
3. BALLARD, F. J., KNOWLES, P. E., WALTON, P. E., EDSON, K., OWENS, P. C., MOHLER, M. A. and FERRAIOLO, B. L., 1991, Plasma clearance and tissue distribution of labeled insulin-like growth factor-I (IGF-I), IGF-II and des(1-3)IGF-I in rats. Journal of Endocrinology, 128, 197-204.
4. BANSKOTA, N. K., CARPENTIER, J. L. and KING, G. L., 1986, Processing and release of insulin and insulin-like growth factor I by macro- and microvascular endothelial cells. Endocrinology, 119, 1904-1913.
5. BESSEY, O. A., LOWRY, O. H. and BROCK, M. J., 1946, A method for the rapid determination of alkaline phosphatase with five cubic millimeters of serum. Journal of Biological Chemistry, 164, 321-329.
6. BHAUMICK, B. and BALA, R. M., 1987, Binding and degradation of insulin-like growth factors I and II by rat kidney membrane. Endocrinology, 120, 1439-1448.
7. CASCIERI, M. A., CHICCHI, G. G., APPLEBAUM, J., GREEN, B. G., HAYES, N. S. and BAYNE, M. L., 1989, Structural analogs of human insulin-like growth factor (IGF) I with altered affinity for type 2 IGF receptors. Journal of Biological Chemistry, 264, 2199-2202.
8. CLAUSSEN, M., KUBLER, B., WENDLAND, M., NEIFER, K., SCHMIDT, B., ZAPF, J. and BRAULKE, T., 1997, Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin D. Endocrinology, 138, 3797-3803.
9. COOKE, R. M., HARVEY, T. S., and CAMPBELL, I. D., 1991, Solution structure of human insulin-like growth factor 1: a nuclear magnetic resonance and restrained molecular dynamics study. Biochemistry, 30, 5484-5491.
10. DIMENT, S., MARTIN, K. J. and STAHL, P. D., 1989, Cleavage of parathyroid hormone in macrophage endosomes illustrate a novel pathway for intracellular processing of proteins. Journal of Biological Chemistry, 264, 13403-13406.
11. DUCKWORTH, W. C., 1988, Insulin degradation: mechanisms, products, and significance. Endocrine Reviews, 9, 319-345.
12. DUCKWORTH, W. C., HAMEL, F. G., PEAVY, D. E., LIEPNIEKS, J. J., RYAN, M. P., HERMODSON, M. A. and FRANK, B. H., 1988, Degradation products of insulin generated by hepatocytes and by insulin protease. Journal of Biological Chemistry, 263, 1826-1833.
13. DUCKWORTH, W. C., HAMEL, F. G., LIEPNIECKS, J., PEAVY, D., FRANK, B. and RABKIN, R., 1989, Insulin degradation products from the perfused rat kidney. American Journal of Physiology, 256, E208-214.
14. FAWCETT, J. and RABKIN, R., 1995, The processing of insulin-like growth factor-I (IGF-I) by a cultured kidney cell line is altered by IGF-binding protein-3. Endocrinology, 136, 1340-1347.
15. FLYVBJERG, A., NIELSEN, S., SHEIKH, M. L., JACOBSEN, C., ORSKOV, H. and CHRISTENSEN, E. I., 1993, Luminal and basolateral uptake and receptor binding of IGF-I in rabbit renal proximal tubules. American Journal of Physiology, 265, F624-633.
16. HAGOPIAN, W. A. and TAGER, H. S., 1987, Hepatic glucagon metabolism. Correlation of hormone processing by isolated canine hepatocytes with glucagon metabolism in man and in the dog. Journal of Clinical Investigation, 79, 409-417.
17. HALBAN, P. A., 1994, Proinsulin processing in the regulated and the constitutive secretory pathway. Diabetologia, 37, S65-72.
18. HALLIDAY, D. A., MCNEIL, J. D. and SCICCHITANO, R., 1993, A metabolite of substance P, SP7-11 is involved in the pathogenesis of inflammatory joint disease. Medical Hypotheses, 40, 227-231.
19. HAMEL, F. G., POSNER, B. I., BERGERON, J. J. M., FRANK, B. H. and DUCKWORTH, W. C., 1988, Isolation of insulin degradation products from endosomes derived from intact rat liver. Journal of Biological Chemistry, 263, 6703-6708.
20. HAYRY, P., MYLLARNIEMI, M., AAVIK, E., ALATALO, S., AHO, P., YILMAZ, S., RAISANEN-SOKOLOWSKI, A., COZZONE, G., JAMESON, B. A. and BASERGA, R., 1995, Stabile D-peptide analog of insulin-like growth factor-1 inhibits smooth muscle cell proliferation after carotid ballooning injury in the rat. FASEB Journal, 9, 1336-1344.
21. HUA, Q. X., GOZANI, S. N., CHANCE, R. E., HOFFMANN, J. A., FRANK, B. H. and WEISS, M. A., 1995, Structure of a protein in a kinetic trap. Nature Structural Biology, 2, 129-138.
22. KAUFMANN, J. E., IRMINGER, J. C. and HALBAN, P. A., 1995, Sequence requirements for proinsulin processing at the B-chain/C-peptide junction. Biochemical Journal, 310, 869-874.
23. KIMURA, T., KANZAKI, Y., MATSUMOTO, Y., MANDAI, M., KUROSAKI, Y. and NAKAYAMA, T., 1994, Disposition of recombinant human insulin-like growth factor-I in normal and hypophysectomized rats. Biological and Pharmaceutical Bulletin, 17, 310-315.
24. KOMPELLA, U. B. and LEE, V. H. L., 1991, Pharmacokinetics of peptide and protein drugs. In V. H. L. Lee (ed.), Peptide and Protein Drug Delivery (New York: Marcel Dekker), pp. 391-484.
25. KOZUYA, H., MATSUURA, N., SAKAMOTO, M., MAKINO, H., SAKAMOTO, Y., KADOWAKI, T., SUZUKI, Y., KOBAYASHI, M., AKAZAWA, Y., NOMURA, M., YOSHIMASA, Y., KASUGA, M., GOJI, K., NAGATAKI, S., OYASU, H. and IMURA, H., 1993, Trial of insulinlike growth factor I therapy for patients with extrme insulin resistance syndromes. Diabetes, 42, 696-705.
26. KREEGER, J. S. and LARSON, A. A., 1996, The substance P amino-terminal metabolite substance P(1-7), administered peripherally, prevents the development of acute morphine tolerance and attenuates the expression of withdrawal in mice. Journal of Pharmacology and Experimental Therapeutics, 279, 662-667.
27. LAOUAR, A., WIETZERBIN, J. and BAUVOIS, B., 1994, Protease-catalyzed conversion of insulin-like growth factor-I and interleukin-6 into high molecular-mass species through the sequential action of hematopoietic surface-associated cathepsin G and gamma-glutamyl transpeptidase-related activities. European Journal of Biochemistry, 223, 617-624.
28. LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurement with the folin phenol reagent. Journal of Biological Chemistry, 193, 265-275.
29. MALY, P. and LUTHI, C., 1988, The binding sites of insulin-like growth factor I (IGF I) to type I IGF receptor and to a monoclonal antibody. Mapping by chemical modification of tyrosine residues. Journal of Biological Chemistry, 263, 7068-7072.
30. MATSUO, N., YASUKURA, M., ETOH, Y., SASAKI, N., OKADA, S., TAJIRI, H., NOSE, O. and NISHI, Y., 1992, Effects of FK780 (recombinant hIGF-I) on growth hormone insensitivity syndromes. Japanese Pharmacology and Therapeutics, 20, 2027-2035.
31. MAUNSBACH, A. B., 1974, Isolation of kidney lysosomes. In S. Fleischer and L. Packer (eds), Methods in Enzymology (New York: Academic), vol. 31, pp. 330-339.
32. OHSHITA, T. and KIDO, H., 1994, Involvement of a cystatin-α-sensitive cysteine proteinase in the degradation of native L-lactate dehydrogenase and serum albumin by rat liver or kidney lysosomes. European Journal of Biochemistry, 225, 781-786.
33. PELL, M. E., DUCKWORTH, W. C. and PEAVY, D. E., 1986, Localization of insulin degradation products to an intracellular site in isolated rat hepatocytes. Biochemical and Biophysical Research Communications, 137, 1034-1040.
34. SAITO, Y., YAMADA, H., NIWA, M. and UEDA, I., 1987, Production and isolation of recombinant somatomedin C. Journal of Biochemistry (Tokyo), 101, 123-134.
35. 1H-NMR and distance geometry. International Journal of Peptide and Protein Research, 41, 433-440.
36. SMEEKENS, S. P., 1993, Processing of protein precursors by a novel family of subtilisin-related mammalian endoproteases. Biotechnology (NY), 11, 182-186.
37. TANAKA, Y., KITAO, K., HATA, T. and KIMURA, T., 1997, Kidney as an important metabolic organ for recombinant human insulin-like growth factor-I. Research Communications in Molecular Pathology and Pharmacology, 96, 267-276.
38. TANDESKI, T. R., YEMM, R. S. and HOSSNER, K. L., 1990, Interaction of insulin-like growth factors (IGF) with isolated sheep hepatocytes. I. Binding and degradation of IGF-I. Domestic Animal Endocrinology, 7, 343-351.
39. VELAZWUEZ, R. A., SUN, X., KURTZ, H. J. and LARSON, A. A., 1993, Possible role of the N-terminus of substance P in kanic acid-induced toxicity in rats. Brain Research, 624, 109-114.
40. WATTIAUX, R. and DUVE, C., 1956, Tissue fraction studies 7. Release of bound hydrolases by means of triton X-100. Biochemical Journal, 63, 606-608.
41. WEISS, A., FRANK, B. H., KHAIT, I., PEKAR, A., HEINEY, R., SHOELSON, S. E. and NEURINGER, L. J., 1990, NR and photo-CIDNP studies of human proinsulin and prohormone processing intermediates with application to endopeptidase recognition. Biochemistry, 29, 8389-8401.
42. WHARTON, D. C. and TZAGOLOFF, A., 1967, Cytochrome oxidase from beef heart mitochondria. In S. Fleischer and L. Packer (eds), Methods in Enzymology (New York: Academic), vol. 10, pp. 245-250.